Prognostic value and immunological role of PDCD1 gene in pan-cancer
Yandong Miao,Jiangtao Wang,Qiutian Li,Wuxia Quan,Yingying Wang,Chen Li,Jingjing Wu,Denghai Mi
DOI: https://doi.org/10.1016/j.intimp.2020.107080
IF: 5.714
2020-12-01
International Immunopharmacology
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>Identify the prognostic value and investigate the association between programmed cell death 1 (PDCD1) gene expression and immune infiltration in pan-cancer.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>We used a series of bioinformatics methods to comprehensively analyze the relationship between <em>PDCD1</em> gene and prognosis, tumor mutational burden (TMB), microsatellite instability (MSI), immune cell infiltration of various cancers from the existing public database, and try to find the potential prognostic value of <em>PDCD1</em> for in pan-cancer.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>High expression of <em>PDCD1</em> was closely related to better overall survival (OS) and disease-specific survival (DSS) in breast invasive carcinoma, head and neck squamous cell carcinoma, skin cutaneous melanoma, and uterine corpus endometrial carcinoma; have a better disease-free interval (DFI) and progression-free interval (PFI) in several cancer types. Meanwhile, the high level of <em>PDCD1</em> gene expression was associated with poorer OS, DSS, and PFI in brain lower grade glioma and uveal melanoma; poorer OS in acute myeloid leukemia and kidney renal papillary cell carcinoma; poorer OS and DSS in glioblastoma multiforme; poorer DSS in kidney renal clear cell carcinoma, by Kaplan-Meier and Cox survival analysis. <em>PDCD1</em> gene expression was significantly correlated with TMB and MSI in 14 and 12 cancer types, respectively, and infiltrating levels of immune cells, especially Macrophages M0, M1, CD4-T-cells, CD8-T-cells, and T cells follicular helper, in most of eight cancer types.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p><em>PDCD1</em> can be used as a prognostic marker in multiple cancers, owing to it is closely associated with TMB, MSI, and immune cells infiltration.</p>
pharmacology & pharmacy,immunology